Clinical SOP: Polysomnography & Wearables to Differentiate Sleep Paralysis from Alleged Possession

Introduction — Purpose and Clinical Rationale

This SOP is written for sleep clinics, neurology services, and multidisciplinary teams asked to evaluate reports of nocturnal "possession" or entity experiences that are phenotypically consistent with sleep paralysis. Its goals are (1) to provide a stepwise, safety‑first clinical pathway for triage and testing; (2) to specify a laboratory polysomnography (PSG) and wearable monitoring protocol that maximizes diagnostic yield; and (3) to supply succinct case and forensic report templates clinicians can adapt for medical, legal, or pastoral stakeholders.

Rationale: isolated and recurrent sleep paralysis are common REM‑dissociation phenomena that can include inability to move, intense fear, and vivid hypnagogic/hypnopompic hallucinations. These presentations frequently prompt help‑seeking across medical and spiritual sectors and therefore require a reproducible, evidence‑based differential assessment.

PSG remains the diagnostic gold standard for physiologic sleep staging and for excluding alternative causes (nocturnal seizures, parasomnias, severe sleep‑disordered breathing). Sleep laboratories and scorers must follow current AASM scoring rules and technical specifications when acquiring and interpreting data.

Protocol Overview — Triage, Consent, and Safety

1. Pre‑visit triage

• Obtain a focused history: episode phenomenology (motor immobility, timing relative to sleep/wake transitions), frequency, hallucination modality (visual/auditory/somatic), injury risk, substance use, psychiatric history, and daytime sleepiness (Epworth Sleepiness Scale).
• Screen for red flags requiring urgent medical/psychiatric care: ongoing psychosis, suicidal ideation, uncontrolled medical illness, suspected intoxication, or behaviors causing harm during sleep (automatisms, violence) — arrange emergency referral if present.
• If episodes are nightly, violent, or associated with altered awareness outside sleep transitions (e.g., awake violence), prioritize inpatient evaluation and neurology/EEG workup for possible nocturnal epilepsy.

2. Informed consent and data governance

• Obtain written informed consent covering: PSG (video/infrared), ECG, continuous oximetry, optional additional sensors (actigraphy/consumer wearables), storage and secondary use of biosignals, and potential sharing of de‑identified data for multidisciplinary review. Clarify limits of confidentiality and mandatory reporting obligations.
• Document chain‑of‑custody for video and wearable exports when findings may be used in legal or pastoral contexts.

3. Safety and accommodations

• Provide a chaperone or family contact, supervised room entry/exit, and immediate access to on‑call clinician if the subject becomes distressed during adaptation nights.
• Offer a preparatory visit or video tour of the sleep lab when cultural or anxiety concerns may preclude accurate assessment.

Note: long‑term or population monitoring with consumer wearables is increasingly used to detect temporal patterns, but device output varies by vendor and should be interpreted with caution alongside PSG. Recent meta‑analytic and society reviews report systematic differences between consumer devices and PSG, especially for sleep staging and wake detection. Use wearables primarily for timeline/context, not as a standalone diagnostic substitute for PSG.

Laboratory PSG + Wearable Monitoring — Technical SOP

1. Recommended montage (adult)

Channel	Purpose
EEG: F3‑M2, F4‑M1, C3‑M2, C4‑M1, O1‑M2, O2‑M1	Accurate sleep staging and detection of REM/NREM dissociation
EOG (2 channels)	Detect REM and slow eye movements
Chin EMG	Assess REM atonia vs motor activity
Limb EMG (tibialis anterior)	Rule out periodic limb movements or parasomnia motor events
ECG (single lead)	Monitor heart rate and rhythm changes; time‑synchronize HRV analysis
Respiratory belts, nasal pressure, oximetry	Exclude sleep‑disordered breathing and hypoxia
Infrared video (synchronized)	Document behaviors and correlate with electrophysiology

Follow AASM technical and scoring specifications for electrode placement, sampling rates, filter settings, and montage naming conventions. Document exact time sources and ensure NTP synchronization across PSG, video, and any wearable devices.

2. Wearable integration

• When available, have the subject wear their regular consumer device (smartwatch/ring) in addition to PSG. Collect raw or highest‑resolution exports (PPG, acceleration, HR, HRV summaries) where vendor policy permits.
• Time‑stamp alignment: record an audible/visual synchronization marker (e.g., clap or light pulse) near lights‑out to align PSG and wearable timelines during post‑processing.
• Use wearables for circadian/timeline patterns (e.g., clustering of events at sleep onset or upon awakening) and for autonomic trend analysis; avoid over‑interpreting stage labels from consumer devices without formal validation in the device and population.

3. Focused recording for suspected sleep paralysis

• Capture full‑night PSG with continuous video. Many sleep‑paralysis episodes occur during transitions (sleep onset or awakening), so ensure continuous pre‑lights‑out and post‑lights‑on recording for at least 30 minutes.
• Consider an adaptation night plus an extended second night if episodes are infrequent but highly symptomatic; for recurrent nightly events, a single night may suffice.

Autonomic correlates (heart rate and HRV) during transitions may show transient sympathetic shifts, but the literature is mixed on whether HR/HRV correlates reliably with subjective distress in ISP. Use HR/HRV as supportive physiologic context, not definitive proof of non‑spiritual causes.

Scoring, Interpretation, and Differential Diagnosis

1. Scoring and annotation

• Score sleep stages using current AASM rules and report latency to REM, REM density, and REM atonia. Annotate micro‑arousals, respiratory events, and any epileptiform transients. Include synchronized video timestamps for any behavior or reported episode.
• If an event occurs, annotate: (a) sleep stage at onset, (b) EEG features (REM‑like vs wake‑like), (c) chin EMG (presence or absence of atonia), (d) heart rate change, and (e) video‑observed motor activity.
• When differential includes nocturnal epilepsy, submit PSG with extended EEG montage or arrange inpatient video‑EEG per neurology guidance; PSG alone may not exclude brief focal seizures.

2. Differential checklist (clinician use)

1. REM‑dissociation (isolated or recurrent sleep paralysis)
2. Narcolepsy spectrum (ask about cataplexy and daytime sleepiness)
3. REM behavior disorder or other parasomnias (look for complex motor patterns inconsistent with REM atonia)
4. Nocturnal epileptic events (consider when stereotyped motor behavior, ictal EEG changes, or post‑ictal confusion present)
5. Intoxication, medication effects, or psychotic disorders (contextual psychiatric assessment required)

Summarize findings in plain language for patients and, where required, in a forensic addendum for legal/pastoral recipients. For forensic contexts, follow best practices for expert witness preparation: document sources, remain within your expertise, and transparently state limitations of the data and any uncertainty.

Case Templates — Quick‑Use Texts for Reports and Communication

1. Brief PSG report template (clinical)

Patient: [Name, DOB, MRN]
Study: In‑lab video‑PSG, Date/Times: [lights out / lights on]
Indication: Recurrent nocturnal immobility with hypnagogic hallucinations — evaluate for sleep paralysis vs parasomnia.

Technical: Standard AASM adult montage (EEG, EOG, chin EMG, bilateral tibialis EMG, ECG, airflow, respiratory effort, oximetry, synchronized infrared video). PSG and video time‑stamped and NTP‑aligned. Patient wore personal consumer wearable (device: [brand/model]) with PPG and accelerometer data exported and time‑synchronized.

Findings:

• Total sleep time: [TST]
• Sleep efficiency: [value]
• Sleep architecture: REM latency [min], % REM [value], % N3 [value]
• Respiratory events: AHI [value] (obstructive/central)
• Event of interest at [hh:mm]: EEG consistent with [REM/N1/wake], chin EMG showed [atonia/activation], video showed [immobility/complex movement], heart rate [stable/increased by X bpm].

Impression: Physiologic evidence consistent with REM‑related sleep paralysis (REM dissociation) with preserved REM atonia during the episode / OR findings inconsistent with ISP and suggestive of [parasomnia / nocturnal seizure / other]. Clinical correlation recommended. Limitations: single‑night recording; consumer wearable stage labels are exploratory.

2. Wearable supplemental summary (one paragraph)

Consumer wearable (brand/model) recorded increased heart rate and movement index beginning at [time] and peaking during the annotated event window. Wearable‑derived sleep staging suggested [stage], but vendor staging has known limitations relative to PSG; wearable data are presented to show temporal context rather than to replace PSG evidence.

3. Forensic addendum checklist (bullet points)

• Confirm identity, chain‑of‑custody for video and wearable exports, and time synchronization logs.
• State clearly: (a) what PSG shows, (b) what PSG cannot exclude, and (c) whether the observed physiology is consistent with a sleep‑based phenomenon.
• Avoid absolute language about metaphysical claims; stick to observable physiology and probability statements (e.g., "findings are consistent with REM‑dissociation phenomena such as sleep paralysis").
• Declare potential confounders: medications, substances, single‑night sampling, incomplete EEG coverage, or missing wearable raw data.
• Append raw traces, annotated screenshots, and synchronized video stills when releasing a redacted forensic bundle. Guidance for expert conduct and reporting in medicolegal settings is available in contemporary forensic sleep literature.

Operational Notes, Limitations, and Follow‑Up

Operational considerations: ensure scorers are trained on the current AASM manual, maintain device validation logs, and when using consumer devices maintain vendor export receipts and versioned firmware notes. The clinic should keep a short SOP annex listing approved wearable models and export procedures, and consent templates that explicitly mention secondary uses of data.

Limitations: consumer wearables vary in accuracy for sleep staging and wake detection; while select devices (manufacturers publish device performance) can have acceptable sensitivity for sleep detection, they do not uniformly reach clinical‑grade staging accuracy and should not be used as single evidence for or against a physiologic diagnosis. Use wearables for longitudinal patterning and patient engagement, not as a substitute for PSG.

Follow‑up: when PSG suggests REM‑dissociation or narcolepsy spectrum, refer back to neurology/sleep medicine for narcolepsy testing (MSLT when indicated), and discuss CBTi, sleep hygiene, and targeted anxiety/trauma interventions. For patients and pastoral partners, provide a non‑judgmental explanation of physiologic mechanisms and a tailored aftercare plan that may include brief psychoeducation about sleep paralysis, safety planning, and mental health referral.